Maximum Retail Prices of Medicines
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
All Marketing Authorization Holders of Medical Devices
All Medical Device Marketing Authorization Holders (MAHs)are hereby informed that the National Medicines Regulatory Authority (NMRA) has decided to collect data relating to pending files of the following applications submitted up to 31st December 2024.
All relevant MAHs are kindly requested to review your records and provide the required details for all pending applications submitted within the above-mentioned period.
Please ensure that the requested information is submitted on or before 31st March 2026.
The details must be entered through the Google form using the link provided below
Click Here: Collecting Data relating to pending files Google form
Average US Dollar Rate March -2026 for Price Approvals of MRP’s by NMRA
Notice to all Authorized Local Agents, This is to kindly inform all authorized local agents that the USD rate considered for the month of March -2026 for processing price details of medicines/ medical devices is 312.95.
Please ensure that all price submissions for MRP approvals are prepared accordingly.
The National Medicines Regulatory Authority hereby informs all medicine importers and local manufacturers in Sri Lanka that registration applications are accepted for the extended release formulations of Methylphenidate, Lisdexamfetamine and other related stimulant medicines used in the management of Attention Deficit Hyperactivity Disorder (ADHD).
